Your browser doesn't support javascript.
loading
Safety and Tolerability of Bilastine 0.6% Ophthalmic Solution: An 8-Weeks Phase III Study.
Kuna, Piotr; Jutel, Marek; Pulka, Grazyna; Tokarski, Slawomir; Arranz, Paula; Hernández, Gonzalo; Fernández Hernando, Nieves.
Afiliação
  • Kuna P; Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
  • Jutel M; Department of Clinical Immunology, Wroclaw Medical University, Wroclaw, Poland.
  • Pulka G; All-Med Medical Research Institute, Wroclaw, Poland.
  • Tokarski S; Centrum Medyczne All-Med, Krakòw, Poland.
  • Arranz P; Institute of Medical Sciences, Medical College of Rzeszow University, Rzeszow, Poland.
  • Hernández G; Department of Research, Development and Innovation, FAES FARMA, Leioa, Bizkaia, Spain.
  • Fernández Hernando N; Department of Research, Development and Innovation, FAES FARMA, Leioa, Bizkaia, Spain.
Clin Ophthalmol ; 17: 735-746, 2023.
Article em En | MEDLINE | ID: mdl-36909350
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2023 Tipo de documento: Article